While Emami is still struggling to push growth, given weak rural demand, the sale of the group s stake in AMRI Hospitals should ease investor concerns about stake pledges by promoters.
It has also carried a series of stake acquisitions which should enable the expansion of its brand portfolio.
The Q2 results are likely to see flat volumes and low revenue growth alongside some gross margin expansion.